Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 71-80 of 287 for heart disease

Edit search filters
  1. Virtual World-based Cardiac Rehabilitation Program to Encourage Healthy Lifestyle Choices Among Cardiac Patients

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. Function of Artificial Intelligence-enabled Electrocardiogram in Early Detection of Patients With Aortic Stenosis

    Rochester, MN

  3. A Study Relating Voice Characteristics and Cardiovascular Disease / Pulmonary Hypertension

    Rochester, MN

  4. Inclisiran For Participants With Atherosclerotic Cardiovascular Disease And Elevated Low-density Lipoprotein Cholesterol

    Rochester, MN

  5. TOCCASTAR - TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation

  6. An Evaluation of the MitraClip System for treatment of Mitral Regurgitation in Heart Failure Patients

    Scottsdale/Phoenix, AZ

  7. A Study Of Atrial Cardiopathy And Antithrombotic Drugs In Prevention After Cryptogenic Stroke

    Jacksonville, FL

  8. A Study To Evaluate Whether Macitentan Is An Effective And Safe Treatment For Patients With Heart Failure With Preserved Ejection Fraction And Pulmonary Vascular Disease

    Scottsdale/Phoenix, AZ

  9. Stroke Mitigation in A-fib Reasoning Tool for Shared Decision Making

    Rochester, MN

  10. Aspirin Dosing: A Patient-Centric Trial Assessing Benefits And Long-term

    Rochester, MN

.

Mayo Clinic Footer